Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue ...

LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported 2024 financial and operational results on February 26 th , producing sales of over $1 billion for Pylarify during ...

Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full ...

Lantheus Holdings, Inc. ( NASDAQ:LNTH ) shareholders have seen the share price descend 19% over the month. But ...

Lantheus Holdings Inc (NASDAQ:LNTH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 ...

Principal Financial Group Inc. reduced its position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F ...

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company ...

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s ...

Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating ...

Lantheus Holdings (NASDAQ: LNTH) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic ...

BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed ...

Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) – Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for shares of Lantheus in a research note issued to ...